MedTrace Logo

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)

NCT03257254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2021-12-14

Study results available
· View outcomes & findings →

Summary

A 12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting in VLU treated with Varithena.

Conditions

  • Venous Leg Ulcer

Interventions

DRUG

Varithena

Administration procedures and volume are per standard of care, full prescribing information, and instructions for use.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Shao, MD · Swedish Covenant Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-29
Primary Completion
2020-05-18
Completion
2020-09-28
FDA Drug
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257254 on ClinicalTrials.gov